Our study indicates that the overexpression of CD36 is associated with decreased progression-free survival in melanoma, and the cancer hallmark enrichment dataset shows that CD36 is associated with reprogramming energy metabolism and tissue invasion or metastasis (Figure 1). The gene discussed is CD36; the disease is melanoma.